GAMMA Investing’s Compass Therapeutics CMPX Stock Holding History

GAMMA Investing’s Portfolio CMPX Stock Details CMPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$810	Buy	779 +337	+76%	+$695	﹤0.01%	4136
2026 Q2	$968	Buy	442 +218	+97%	+$644	﹤0.01%	3888
2026 Q1	$1.19K	Buy	224 +195	+672%	+$1.13K	﹤0.01%	3802
2025 Q4	$156	Buy	+29	New	+$134	﹤0.01%	4022

Other funds holding CMPX

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's CMPX Position: Q3 2026 in Review

GAMMA Investing increased its Compass Therapeutics (CMPX) stake by 76% in Q3 2026, buying an estimated $695 and bringing the position to 779 shares worth $810. The position accounts for ﹤0.01% of the portfolio, ranked #4136.

GAMMA Investing first reported a position in CMPX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.19K in Q1 2026. 2 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.

GAMMA Investing held 779 shares of Compass Therapeutics worth $810 as of Q3 2026.
GAMMA Investing bought 337 Compass Therapeutics shares in Q3 2026, an estimated $695.
Compass Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4136 holding.
GAMMA Investing first reported a position in Compass Therapeutics in Q4 2025 and has held it in 4 quarters since.
GAMMA Investing's Compass Therapeutics position peaked at $1.19K in Q1 2026.
2 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.